دورية أكاديمية
أعرض في EDS

Emerging histopathological parameters in the prognosis of oral squamous cell carcinomas.

التفاصيل البيبلوغرافية
العنوان: Emerging histopathological parameters in the prognosis of oral squamous cell carcinomas.
المؤلفون: de Morais EF; Department of Oral Diagnosis and Graduate Program in Oral Biology, Piracicaba Dental School, University of Campinas, Piracicaba, São Paulo, Brazil., Almangush A; Department of Pathology, University of Turku, Turku, Finland.; Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland., Salo T; Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland.; Research Unit of Population Health, University of Oulu and Oulu University Hospital, Oulu, Finland., da Silva SD; Lady Davis Institute for Medical Research and Segal Cancer Center, Jewish General Hospital, and Department of Otolaryngology-Head and Neck Surgery, McGill University, Montreal, Quebec, Canada., Kujan O; UWA Dental School, The University of Western Australia, Perth, WA, Australia., Coletta RD; Department of Oral Diagnosis and Graduate Program in Oral Biology, Piracicaba Dental School, University of Campinas, Piracicaba, São Paulo, Brazil. coletta@fop.unicamp.br.
المصدر: Histology and histopathology [Histol Histopathol] 2024 Jan; Vol. 39 (1), pp. 1-12. Date of Electronic Publication: 2023 May 29.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Histology and Histopathology Country of Publication: Spain NLM ID: 8609357 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-5848 (Electronic) Linking ISSN: 02133911 NLM ISO Abbreviation: Histol Histopathol Subsets: MEDLINE
أسماء مطبوعة: Publication: Murcia : Histology and Histopathology
Original Publication: Murcia, Spain : Gutenberg, 1986-
مواضيع طبية MeSH: Carcinoma, Squamous Cell*/diagnosis , Carcinoma, Squamous Cell*/pathology , Mouth Neoplasms*/diagnosis , Mouth Neoplasms*/pathology , Head and Neck Neoplasms*/pathology, Humans ; Squamous Cell Carcinoma of Head and Neck/pathology ; Prognosis ; Neoplasm Staging ; Retrospective Studies
مستخلص: Oral squamous cell carcinoma (OSCC) is the most common oral malignancy, representing 90% of all malignant neoplasms in the head and neck region. Patients with this aggressive tumor have an overall 5-year survival rate of approximately 50%, which drops to less than 30% when tumors are diagnosed at advanced clinical stages. Over decades, several studies provided high-level evidence of the impact of histopathological features on treatment guidelines and prognosis of OSCC. The 8th American Joint Committee on Cancer (AJCC) TNM staging system recognized the importance of depth of invasion to the T category and extranodal extension to the N category for OSCC. This review provides the current knowledge on emerging histopathological parameters identified as potential biomarkers for OSCC, such as depth of invasion, tumor thickness, the pattern of invasion, inflammatory profile, and tumor-stroma ratio, evaluating their clinical relevance on patient outcomes. Analysis, limitations, and potential biological mechanisms are highlighted and discussed. Assessing and reporting these markers are cost-effective and can be incorporated into daily practice.
(©The Author(s) 2024. Open Access. This article is licensed under a Creative Commons CC-BY International License.)
References: Almangush A., Bello I.O., Keski-Säntti H., Mäkinen L.K., Kauppila J.H., Pukkila M., Hagström J., Laranne J., Tommola S., Nieminen O., Soini Y., Kosma V. M., Koivunen P., Grénman R., Leivo I. and Salo T. (2014). Depth of invasion, tumor budding, and worst pattern of invasion: Prognostic indicators in early-stage oral tongue cancer. Head Neck 36, 811-818. (PMID: PMC422906623696499)
Almangush A., Coletta R.D., Bello I.O., Bitu C., Keski-Säntti H., Mäkinen L.K., Kauppila J.H., Pukkila M., Hagström J., Laranne J., Tommola S., Soini Y., Kosma V.M., Koivunen P., Kowalski L.P., Nieminen P., Grénman R., Leivo I. and Salo T. (2015). A simple novel prognostic model for early stage oral tongue cancer. Int. J. Oral. Maxillofac. Surg. 44, 143-150. (PMID: 25457829)
Almangush A., Heikkinen I., Mäkitie A.A., Coletta R.D., Läärä E., Leivo I. and Salo, T. (2017). Prognostic biomarkers for oral tongue squamous cell carcinoma: A systematic review and meta-analysis. Br. J. Cancer 117, 856-866. (PMID: PMC558999228751758)
Almangush A., Mäkitie A.A., Mäkinen LK., Kauppila J.H., Pukkila M., Hagström J., Laranne J., Soini Y., Kowalski L.P., Grénman R., Haglund C., Coletta R.D., Salo T. and Leivo I. (2018a). Small oral tongue cancers (≤ 4 cm in diameter) with clinically negative neck: from the 7th to the 8th edition of the American Joint Committee on Cancer. Virchows Arch. 473, 481-487. (PMID: 30039390)
Almangush A., Pirinen M., Heikkinen I., Mäkitie A.A., Salo T. and Leivo I. (2018b). Tumour budding in oral squamous cell carcinoma: a meta-analysis. Br. J. Cancer 118, 577-586. (PMID: PMC583058929190636)
Almangush A., Heikkinen I., Bakhti N., Mäkinen L.K., Kauppila J.H. and Pukkila M. (2018c). Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers. Histopathology 72, 1128-1135. (PMID: 29427291)
Almangush A., Youssef O., Pirinen M., Sundström J., Leivo I. and Mäkitie A.A. (2019). Does evaluation of tumour budding in diagnostic biopsies have a clinical relevance? A systematic review. Histopathology 74, 536-544. (PMID: 30450728)
Almangush A., Bello I.O., Heikkinen I., Hagström J., Haglund C., Kowalski L.P., Coletta R.D., Mäkitie, A.A., Salo T. and Leivo I. (2021a). Improving risk stratification of early oral tongue cancer with TNM-Immune (TNM-I) staging system. Cancers 13, 3235. (PMID: PMC826763734209490)
Almangush A., Alabi R.O., Troiano G., Coletta R.D., Salo T., Pirinen M., Mäkitie A.A. and Leivo I. (2021b). Clinical significance of tumor- stroma ratio in head and neck cancer: A systematic review and meta-analysis. BMC Cancer 21, 480. (PMID: PMC808607233931044)
Almangush A., De Keukeleire S., Rottey S., Ferdinande L., Vermassen T., Leivo I. and Mäkitie A.A. (2022). Tumor-infiltrating lymphocytes in head and neck cancer: Ready for prime time? Cancers 14, 1558. (PMID: PMC894662635326709)
Alsaffar H.A., Goldstein D.P., King E.V., de Almeida J.R., Brown D.H., Gilbert R.W., Gullane P.J., Espin-Garcia O., Xu W. and Irish J.C. (2016). Correlation between clinical and MRI assessment of depth of invasion in oral tongue squamous cell carcinoma. J. Otolaryngol. Head Neck Surg. 45, 61. (PMID: PMC512048027876067)
Amin M.B., Greene F.L., Edge S.B., Compton C.C., Gershenwald J.E., Brookland R.K., Meyer L., Gress D.M., Byrd D.R. and Winchester, D.P. (2017). The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J. Clin. 67, 93-99. (PMID: 28094848)
Asif P.J., Longobardi C., Hahne M. and Medema J.P. (2021). The role of cancer-associated fibroblasts in cancer invasion and metastasis. Cancers, 13, 4720. (PMID: PMC847258734572947)
Badalamenti G., Fanale D., Incorvaia L., Barraco N., Listì A., Maragliano R., Vincenzi, B., Calò V., Iovanna J. L., Bazan V. and Russo A. (2019). Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone? Cell Immunol. 343, 103753. (PMID: 29395859)
Barriere G., Fici P., Gallerani G., Fabbri F. and Rigaud M. (2015). Epithelial mesenchymal transition: a double-edged sword. Clin. Transl. Med. 4, 14. (PMID: PMC440960425932287)
Bello I. O., Wennerstrand P. M., Suleymanova I., Siponen M., Qannam A., Nieminen P., Leivo I., Almangush A. and Salo T. (2021). Biopsy quality is essential for preoperative prognostication in oral tongue cancer. APMIS 129, 118-127. (PMID: 33320967)
Binnewies M., Roberts E.W., Kersten K., Chan V., Fearon D.F., Merad M., Coussens L. M., Gabrilovich D.I., Ostrand-Rosenberg S., Hedrick C.C., Vonderheide R.H., Pittet M.J., Jain R.K., Zou W., Howcroft T.K., Woodhouse E.C., Weinberg R.A. and Krummel M.F. (2018). Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat. Med. 24, 541-550. (PMID: PMC599882229686425)
Bjerkli I.H., Laurvik H., Nginamau E.S., Søland T.M., Costea D., Hov H., Uhlin-Hansen L., Hadler-Olsen E. and Steigen S.E. (2020). Tumor budding score predicts lymph node status in oral tongue squamous cell carcinoma and should be included in the pathology report. PLoS One 15, e0239783. (PMID: PMC751859132976535)
Bruschini R., Maffini F., Chiesa F., Lepanto D., De Berardinis R., Chu F., Tagliabue M., Giugliano G. and Ansarin M. (2021). Oral cancer: Changing the aim of the biopsy in the age of precision medicine. A review. Acta Otorhinolaryngol. Ital. 41, 108-119. (PMID: PMC814272934028455)
Bryne M. (1998). Is the invasive front of an oral carcinoma the most important area for prognostication? Oral Dis. 4, 70-77. (PMID: 9680893)
Burkholder B., Huang R.Y., Burgess R., Luo S., Jones V.S., Zhang W., Lv Z.Q., Gao, C.Y., Wang B.L., Zhang Y.M. and Huang R.P. (2014). Tumor-induced perturbations of cytokines and immune cell networks. Biochim. Biophys. Acta 1845, 182-201. (PMID: 24440852)
Chinn S.B. and Myers J.N. (2015). Oral cavity carcinoma: current management, controversies, and future directions. J. Clin. Oncol. 33, 3269-3276. (PMID: PMC532091926351335)
Coletta R.D., Yeudall W.A. and Salo T. (2020). Grand challenges in oral cancers. Front Oral Health 1, 3. (PMID: PMC532091926351335)
Curry J.M., Sprandio J., Cognetti D., Luginbuhl A., Bar-ad V., Pribitkin E. and Tuluc M. (2014). Tumor microenvironment in head and neck squamous cell carcinoma. Semin. Oncol. 41, 217-234. (PMID: PMC532091926351335)
de Morais E.F., de Farias Morais H.G., de Moura Santos E., Barboza C.A G., Téo F.H., Salo T., Coletta R.D. and de Almeida Freitas R. (2023). TWIST1 regulates proliferation, migration, and invasion and is a prognostic marker for oral tongue squamous cell carcinoma. J. Oral Pathol. Med. 52, 127-135. (PMID: 36285599)
Dirven R., Ebrahimi A., Moeckelmann N., Palme C.E., Gupta R. and Clark, J. (2017). Tumor thickness versus depth of invasion - Analysis of the 8th edition American Joint Committee on Cancer Staging for oral cancer. Oral Oncol. 74, 30-33. (PMID: 29103748)
Dolens E.D.S., Dourado M.R., Almangush A., Salo T.A., Gurgel Rocha C.A., da Silva S.D., Brennan P.A. and Coletta, R.D. (2021). The impact of histopathological features on the prognosis of oral squamous cell carcinoma: a comprehensive review and meta- analysis. Front. Oncol. 11, 784924. (PMID: PMC863128034858861)
Domingueti C.B., Miwa K.Y.M., Dourado M.R., Sawazaki-Calone, Í., Salo T.A., Paranaíba L.M.R. and Coletta R.D. (2021). Prognostication for oral carcinomas based on two histological scoring systems (BD and iBD models). Oral. Dis. 27, 894-899. (PMID: 32772480)
Dourado M.R., Miwa K.Y.M., Hamada G.B., Paranaíba L.M.R., Sawazaki-Calone Í., Domingueti C.B., Ervolino de Oliveira C., Furlan E.C.B., Longo B.C., Almangush A., Salo T. and Coletta R.D. (2020). Prognostication for oral squamous cell carcinoma patients based on the tumour-stroma ratio and tumour budding. Histopathology 76, 906-918. (PMID: 31984527)
Edge S.B. and Compton C.C. (2010). The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol. 17, 1471-1474. (PMID: 20180029)
Elseragy A., Bello I.O., Wahab A., Coletta R.D., Mäkitie A.A., Leivo I., Almangush A. and Salo, T. (2022). Emerging histopathologic markers in early-stage oral tongue cancer: A systematic review and meta-analysis. Head Neck 44, 1481-1491. (PMID: PMC954547935229398)
Fu Y., Zhang X., Ding Z., Zhu N., Song Y., Zhang X., Jing Y., Yu Y., Huang X., Zhang L., Hu Q., Ni Y. and Ding L. (2021). Worst pattern of perineural invasion redefines the spatial localization of nerves in oral squamous cell carcinoma. Front. Oncol. 11, 766902. (PMID: PMC866717034912713)
Georgaki M., Theofilou V.I., Pettas E., Stoufi E., Younis R. H., Kolokotronis A., Sauk J.J. and Nikitakis N.G. (2021). Understanding the complex pathogenesis of oral cancer: A comprehensive review. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 132, 566-579. (PMID: 34518141)
Guan X., Lin L., Chen J., Hu Y., Sun P., Tian H., Maruyama A. and Chen X. (2019). Efficient PD-L1 gene silence promoted by hyaluronidase for cancer immunotherapy. J. Control. Release 293, 104-112. (PMID: 30476528)
Haga K., Yamazaki M., Maruyama S., Kawaharada M., Suzuki A., Hoshikawa E., Chan N.N., Funayama A., Mikami T., Kobayashi T., Izumi K. and Tanuma J.I. (2021). Crosstalk between oral squamous cell carcinoma cells and cancer-associated fibroblasts via the TGF- β/SOX9 axis in cancer progression. Transl. Oncol. 14, 101236. (PMID: PMC850277634624685)
Hapach L.A., Mosier J.A., Wang W and Reinhart-King C.A. (2019). Engineered models to parse apart the metastatic cascade. NPJ Precis. Oncol. 3, 20. (PMID: PMC670409931453371)
Heikkinen I., Bello I.O., Wahab A., Hagström J., Haglund C., Coletta R.D., Nieminen P., Mäkitie A.A., Salo T., Leivo I. and Almangush A. (2019). Assessment of tumor-infiltrating lymphocytes predicts the behavior of early-stage oral tongue cancer. Am. J. Surg. Pathol. 43, 1392-1396. (PMID: 31290758)
Hendry S., Salgado R., Gevaert T., Russell P.A., John T., Thapa B., Christie M., van de Vijver K., Estrada M.V., Gonzalez-Ericsson P.I., Sanders M., Solomon B., Solinas C., Van den Eynden G.G.G.M., Allory Y., Preusser M., Hainfellner J., Pruneri G., Vingiani A., Demaria S., Symmans F., Nuciforo P., Comerma L., Thompson E.A., Lakhani S., Kim S.-R., Schnitt S., Colpaert C., Sotiriou C., Scherer S.J., Ignatiadis M., Badve S., Pierce R.H., Viale G., Sirtaine N., Penault-Llorca F., Sugie T., Fineberg S., Paik S., Srinivasan A., Richardson A., Wang Y., Chmielik E., Brock J., Johnson D.B., Balko J., Wienert S., Bossuyt V., Michiels S., Ternes N., Burchardi N., Luen S.J., Savas P., Klauschen F., Watson P.H., Nelson B.H., Criscitiello C., O'Toole S., Larsimont D., de Wind R., Curigliano G., André F., Lacroix-Triki M., van de Vijver M., Rojo F., Floris G., Bedri S., Sparano J., Rimm D., Nielsen T., Kos Z., Hewitt S., Singh B., Farshid G., Loibl S., Allison K.H., Tung N., Adams S., Willard-Gallo K., Horlings H.M., Gandhi L., Moreira A., Hirsch F., Dieci M.V., Urbanowicz M., Brcic I., Korski K., Gaire F., Koeppen H., Lo A., Giltnane J., Rebelatto M.C., Steele K.E., Zha J., Emancipator K., Juco J.W., Denkert C., Reis-Filho J., Loi S. and Fox S.B. (2017). Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immunooncology biomarkers working group: Part 1: Assessing the host immune response, TILs in invasive breast carcinoma and ductal carcinoma in situ, metastatic tumor deposits and areas for further research. Adv. Anat. Pathol. 24, 235-251. (PMID: PMC556444828777142)
Hiam-Galvez K.J., Allen B.M. and Spitzer M.H. (2021). Systemic immunity in cancer. Nat. Rev. Cancer 21, 345-359. (PMID: PMC803427733837297)
Huang S.H., Hwang D., Lockwood G., Goldstein D.P. and O'Sullivan B. (2009). Predictive value of tumor thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity: A meta- analysis of reported studies. Cancer 115, 1489-1497. (PMID: 19197973)
International Consortium for Outcome Research (ICOR) in Head and Neck Cancer, Ebrahimi A., Gil Z., Amit M., Yen T.C., Liao C.T., Chaturvedi P., Agarwal J.P., Kowalski L.P., Kreppel M., Cernea C.R., Brandao J., Bachar G., Bolzoni Villaret A., Fliss D., Fridman E., Robbins K.T., Shah J.P., Patel S.G. and Clark J.R. (2014). Primary tumor staging for oral cancer and a proposed modification incorporating depth of invasion: An international multicenter retrospective study. JAMA Otolaryngol. Head Neck Surg. 140, 1138- 1148. (PMID: 25075712)
Joosse S.A., Gorges T. M. and Pantel K. (2015). Biology, detection, and clinical implications of circulating tumor cells. EMBO Mol. Med. 7, 1- 11. (PMID: PMC430966325398926)
Kane S.V., Gupta M., Kakade A.C. and D' Cruz A. (2006). Depth of invasion is the most significant histological predictor of subclinical cervical lymph node metastasis in early squamous carcinomas of the oral cavity. Eur. J. Surg. Oncol. 32, 795-803. (PMID: 16777368)
Klintrup K., Mäkinen J.M., Kauppila S., Väre P.O., Melkko J., Tuominen H., Tuppurainen K., Mäkelä J., Karttunen T. J. and Mäkinen M.J. (2005). Inflammation and prognosis in colorectal cancer. Eur. J. Cancer. 41, 2645-2654. (PMID: 16239109)
Landskron G., De la Fuente M., Thuwajit P., Thuwajit C. and Hermoso M.A. (2014). Chronic inflammation and cytokines in the tumor microenvironment. J. Immunol. Res. 2014, 149185. (PMID: PMC403671624901008)
Lee Y.J., Kwon T.G., Kim J.W., Lee S.T., Hong S.H. and Choi S.Y. (2021). Evaluation of depth of invasion and tumor thickness as a prognostic factor for early-stage oral squamous cell carcinoma: A retrospective study. Diagnostics (Basel) 12, 20. (PMID: PMC877445835054187)
Liu B., Amaratunga R., Veness M., Wong E., Abdul-Razak M., Coleman H., Gebski V. and Sundaresan P. (2020). Tumor depth of invasion versus tumor thickness in guiding regional nodal treatment in early oral tongue squamous cell carcinoma. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 129, 45-50. (PMID: 31606422)
Lugli A., Kirsch R., Ajioka Y., Bosman F., Cathomas G., Dawson H., El Zimaity H., Fléjou J.F., Hansen T.P., Hartmann A., Kakar S., Langner C., Nagtegaal I., Puppa G., Riddell R., Ristimäki A., Sheahan K., Smyrk T., Sugihara K., Terris B., Ueno H., Vieth M., Zlobec I. and Quirke P. (2017). Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Mod. Pathol. 30, 1299-1311. (PMID: 28548122)
Mao M.H., Wang S., Feng Z.E., Li J.Z., Li H., Qin L.Z. and Han Z.X. (2019). Accuracy of magnetic resonance imaging in evaluating the depth of invasion of tongue cancer. A prospective cohort study. Oral Oncol. 91, 79-84. (PMID: 30926067)
Marangon Junior H., Melo V.V.M., Caixeta Â.B., Souto G.R., Souza P.E.A., de Aguiar M.C.F. and Horta M.C.R. (2019). Immuno- localization of cancer stem cells marker ALDH1 and its association with tumor budding in oral squamous cell carcinoma. Head Neck Pathol. 13, 535-542. (PMID: PMC685413930430416)
Marsh T., Pietras K. and McAllister S.S. (2012). Fibroblasts as architects of cancer pathogenesis. Biochim. Biophys. Acta 1832, 1070-1078. (PMID: PMC377558223123598)
Mei Z., Huang J.W., Qiao B. and Lam A.K.Y. (2020). Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma. Int. J. Oral Sci. 12, 16. (PMID: PMC725344432461587)
Melchers L.J., Schuuring E., van Dijk B.A., de Bock G.H., Witjes M.J., van der Laan B.F., van der Wal J E. and Roodenburg J.L. (2012). Tumour infiltration depth ≥4 mm is an indication for an elective neck dissection in pT1cN0 oral squamous cell carcinoma. Oral Oncol. 48, 337-342. (PMID: Melchers L.J., Schuuring E., van Dijk B.A., de Bock G.H., Witjes M.J., van der Laan B.F., van der Wal J E. and Roodenburg J.L. (2012). Tumour infiltration depth ≥4 mm is an indication for an elective neck dissection in pT1cN0 oral squamous cell carcinoma. Oral Oncol. 48, 337-342.)
Mesker W.E., Junggeburt J.M., Szuhai K., de Heer P., Morreau H., Tanke H.J. and Tollenaar R.A. (2007). The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage. Cell Oncol. 29, 387-398. (PMID: PMC461799217726261)
Miranda-Filho A. and Bray F. (2020). Global patterns and trends in cancers of the lip, tongue and mouth. Oral Oncol. 102, 104551. (PMID: 31986342)
Mishra A., Das A., Dhal I., Shankar R., Bhavya B. M., Singh N., Tripathi P., Daga D., Rai A., Gupta M. and Sahu G.C. (2022). Worst pattern of invasion in oral squamous cell carcinoma is an independent prognostic factor. J. Oral Biol. Craniofac. Res. 12, 771-776. (PMID: PMC948971936159069)
Mohan S.P., Bhaskaran M.K., George A.L., Thirutheri A., Somasundaran M. and Pavithran A. (2019). Immunotherapy in oral cancer. J. Pharm. Bioallied Sci. 11, S107-S111. (PMID: PMC655531831198321)
Morais E.F., Morais H.G., Martins H.D., Carlan L.M., Costa A.D. and Freitas R.D. (2022). Prognostic and clinicopathological significance of tumor-stroma ratio in head and neck squamous cell carcinoma: A systematic review. Med. Oral. Patol. Oral Cir. Bucal. 27, e301-e309. (PMID: PMC927135135717622)
Muenst S., Laubli H., Soysal S.D., Zippelius A., Tzankov A. and Hoeller S. (2016). The immune system and cancer evasion strategies: therapeutic concepts. J. Intern. Med. 279, 541-562. (PMID: 26748421)
O'Higgins C., Ward F.J. and Abu Eid R. (2018). Deciphering the role of regulatory CD4 T cells in oral and oropharyngeal cancer: A systematic review. Front. Oncol. 8, 442. (PMID: PMC623293130460193)
Pansini P.F., do Valle I.B., Damasceno T.C.D., de Abreu P.M., Có A.C.G., López R.V. M., Lenzi J., Rocha R.M., Souza E.D., Curado M.P., Mehanna H., Nankivell P., de Podestá J.R.V. and von Zeidler S.V. (2021). Differential expression of potential biomarkers of oral squamous cell carcinoma development. Head Neck Pathol. 15, 1127-1136. (PMID: PMC863304333840043)
Ping Q., Yan R., Cheng X., Wang W., Zhong Y., Hou Z., Shi Y., Wang C. and Li R. (2021). Cancer-associated fibroblasts: Overview, progress, challenges, and directions. Cancer Gene Ther. 28, 984- 999. (PMID: 33712707)
Piva M.R., DE Souza L.B., Martins-Filho P.R., Soares R.C., De Santana Santos T. and De Souza Andrade E.S. (2011). Role of inflammation in oral carcinogenesis (Part I): Histological grading of malignancy using a binary system. Oncol. Lett. 2, 1225-1231. (PMID: 33712707)
Pluhar G.E., Pennell C.A. and Olin M.R. (2015). CD8+T cell-independent immune-mediated mechanisms of anti-tumor activity. Crit. Rev. Immunol. 35, 153-172. (PMID: PMC487093326351148)
Qiu J., Jiang E. and Shang Z. (2023). Prognostic value of tumor-stroma ratio in oral carcinoma: Role of cancer-associated fibroblasts. Oral Dis. 29, 1967-1978. (PMID: 35388593)
Ronca R., Van Ginderachter J.A. and Turtoi A. (2018). Paracrine interactions of cancer-associated fibroblasts, macrophages and endothelial cells: Tumor allies and foes. Curr. Opin. Oncol. 30, 45- 53. (PMID: 29084000)
Salama A.M., Valero C., Katabi N., Khimraj A., Yuan A., Zanoni D.K., Ganly I., Patel S.G., Ghossein R. and Xu B. (2021). Depth of invasion versus tumour thickness in early oral tongue squamous cell carcinoma: which measurement is the most practical and predictive of outcome? Histopathology 79, 325-337. (PMID: PMC807956133112422)
Schiavoni G., Gabriele L. and Mattei F. (2013). The tumor microenvironment: A pitch for multiple players. Front. Oncol. 3, 90. (PMID: PMC362836223616948)
Seki M., Sano T., Yokoo S. and Oyama T. (2017). Tumour budding evaluated in biopsy specimens is a useful predictor of prognosis in patients with cN0 early stage oral squamous cell carcinoma. Histopathology 70, 869-879. (PMID: 27926795)
Shan Q., Takabatake K., Kawai H., Oo M. W., Sukegawa S., Fujii M., Nakano K. and Nagatsuka, H. (2022). Crosstalk between cancer and different cancer stroma subtypes promotes the infiltration of tumor-associated macrophages into the tumor microenvironment of oral squamous cell carcinoma. Int. J. Oncol. 60, 78. (PMID: PMC909776735514301)
Shan Q., Takabatake K., Omori H., Kawai H., Oo M. W., Nakano K., Ibaragi S., Sasaki A. and Nagatsuka H. (2021). Stromal cells in the tumor microenvironment promote the progression of oral squamous cell carcinoma. Int. J. Oncol. 59, 72. (PMID: PMC836062134368860)
Shim S.J., Cha J., Koom W.S., Kim G.E., Lee C.G., Choi E.C. and Keum K.C. (2010). Clinical outcomes for T1-2N0-1 oral tongue cancer patients underwent surgery with and without postoperative radiotherapy. Radiat. Oncol. 5, 43. (PMID: PMC288788820504371)
Shimizu S., Miyazaki A., Sonoda T., Koike K., Ogi K., Kobayashi J.I., Kaneko T., Igarashi T., Ueda M., Dehari H., Miyakawa A., Hasegawa T. and Hiratsuka H. (2018). Tumor budding is an independent prognostic marker in early stage oral squamous cell carcinoma: With special reference to the mode of invasion and worst pattern of invasion. PLoS One 13, e0195451. (PMID: PMC590960929672550)
Shrihari T.G. (2017). Dual role of inflammatory mediators in cancer. Ecancermedicalscience 11, 721. (PMID: PMC533639128275390)
Silva G.V.D., da Silva Dolens E., Paranaíba L.M.R., Ayroza A.L.C., Gurgel Rocha C.A., Almangush A., Salo T., Brennan P.A. and Coletta R.D. (2023). Exploring the combination of tumor-stroma ratio, tumor-infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early-stage oral squamous cell carcinoma prognosis. J. Oral Pathol. Med. 52, 402-409. (PMID: 36149755)
Sung H., Ferlay J., Siegel R. L., Laversanne M., Soerjomataram I., Jemal A. and Bray F. (2021). Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209-249. (PMID: 33538338)
Tarin D. (2012). Clinical and biological implications of the tumor microenvironment. Cancer Microenviron. 5, 95-112. (PMID: PMC339906422782446)
Tarin D. (2013). Role of the host stroma in cancer and its therapeutic significance. Cancer Metastasis Rev. 32, 553-566. (PMID: 23625010)
Togni L., Caponio V.C.A., Zerman N., Troiano, G., Zhurakivska K., Lo Muzio L., Balercia A., Mascitti M. and Santarelli A. (2022). The emerging impact of tumor budding in oral squamous cell carcinoma: Main issues and clinical relevance of a new prognostic marker. Cancers 14, 3571. (PMID: PMC933207035892830)
Valkenburg K.C., de Groot A.E. and Pienta K.J. (2018). Targeting the tumour stroma to improve cancer therapy. Nat. Rev. Clin. Oncol. 15, 366-381. (PMID: PMC596043429651130)
van Lanschot C.G.F., Klazen Y.P., de Ridder M. A.J., Mast H., Ten Hove, I., Hardillo J.A., Monserez D.A., Sewnaik A., Meeuwis C.A., Keereweer S., Aaboubout Y., Barroso E.M., van der Toom Q.M., Bakker Schut T.C., Wolvius E.B., Baatenburg de Jong R.J., Puppels G.J. and Koljenović S. (2020). Depth of invasion in early stage oral cavity squamous cell carcinoma: The optimal cut-off value for elective neck dissection. Oral Oncol. 111, 104940. (PMID: 32769035)
Wang C., Huang H., Huang Z., Wang A., Chen X., Huang L., Zhou X. and Liu X. (2011). Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma. J. Oral Pathol. Med. 40, 545-551. (PMID: PMC313570521481005)
Warnakulasuriya S. and Kerr A.R. (2021). Oral cancer screening: Past, present, and future. J. Dent. Res. 100, 1313-1320. (PMID: PMC852929734036828)
Wong T. and Wiesenfeld D. (2018). Oral Cancer. Aust. Dent. J. 63, S91- S99. (PMID: 29574808)
Wu J., Liang C., Chen M. and Su W. (2016). Association between tumor-stroma ratio and prognosis in solid tumor patients: a systematic review and meta-analysis. Oncotarget 7, 68954-68965. (PMID: PMC535660327661111)
Xu C., Yuan J., Kang L., Zhang X., Wang L., Chen X., Yao Q. and Li H. (2020). Significance of depth of invasion determined by MRI in cT1N0 tongue squamous cell carcinoma. Sci. Rep. 10, 4695. (PMID: PMC707014432170092)
Yin P., Su Y., Chen S., Wen J., Gao F., Wu Y. and Zhang X. (2021). MMP-9 knockdown inhibits oral squamous cell carcinoma lymph node metastasis in the nude mouse tongue-xenografted model through the RhoC/Src pathway. Anal. Cell Pathol. 2021, 6683391. (PMID: PMC800438533828938)
Yu P., Wang W., Zhuang Z., Xie N., Xu J., Wang C., Hou J., Han X. and Liu X. (2019). A novel prognostic model for tongue squamous cell carcinoma based on the characteristics of tumour and its microenvironment: iBD score. Histopathology 74, 766-779. (PMID: 30444275)
معلومات مُعتمدة: 2022/00994-5 Fundação de Amparo à Pesquisa do Estado de São Paulo-FAPESP
تواريخ الأحداث: Date Created: 20230613 Date Completed: 20240103 Latest Revision: 20240103
رمز التحديث: 20240103
DOI: 10.14670/HH-18-634
PMID: 37310089
قاعدة البيانات: MEDLINE
الوصف
تدمد:1699-5848
DOI:10.14670/HH-18-634